Therefore, we studied the relationship between IL-32 gene expression and tumor-infiltrating immune cells using quanTIseq, a recently described computational approach to estimate the relative proportions of various tumor infiltrating immune cells from bulk tumor RNA-Seq profiles (33). This evidence concerns the gene IL32 and neoplasm.